These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 19428332)

  • 1. 7-Diethylamino-3(2'-benzoxazolyl)-coumarin is a novel microtubule inhibitor with antimitotic activity in multidrug resistant cancer cells.
    Kim SN; Kim NH; Park YS; Kim H; Lee S; Wang Q; Kim YK
    Biochem Pharmacol; 2009 Jun; 77(12):1773-9. PubMed ID: 19428332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-mitotic potential of 7-diethylamino-3(2'-benzoxazolyl)-coumarin in 5-fluorouracil-resistant human gastric cancer cell line SNU620/5-FU.
    Kim NH; Kim SN; Oh JS; Lee S; Kim YK
    Biochem Biophys Res Commun; 2012 Feb; 418(4):616-21. PubMed ID: 22301191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salvinal, a novel microtubule inhibitor isolated from Salvia miltiorrhizae Bunge (Danshen), with antimitotic activity in multidrug-sensitive and -resistant human tumor cells.
    Chang JY; Chang CY; Kuo CC; Chen LT; Wein YS; Kuo YH
    Mol Pharmacol; 2004 Jan; 65(1):77-84. PubMed ID: 14722239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BPR0L075, a novel synthetic indole compound with antimitotic activity in human cancer cells, exerts effective antitumoral activity in vivo.
    Kuo CC; Hsieh HP; Pan WY; Chen CP; Liou JP; Lee SJ; Chang YL; Chen LT; Chen CT; Chang JY
    Cancer Res; 2004 Jul; 64(13):4621-8. PubMed ID: 15231674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2-(Naphthalene-1-yl)-6-pyrrolidinyl-4-quinazolinone inhibits skin cancer M21 cell proliferation through aberrant expression of microtubules and the cell cycle.
    Wu YC; Hour MJ; Leung WC; Wu CY; Liu WZ; Chang YH; Lee HZ
    J Pharmacol Exp Ther; 2011 Sep; 338(3):942-51. PubMed ID: 21652781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenylcinnamides as novel antimitotic agents.
    Leslie BJ; Holaday CR; Nguyen T; Hergenrother PJ
    J Med Chem; 2010 May; 53(10):3964-72. PubMed ID: 20411988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microtubule-damaging agents enhance RASSF1A-induced cell death in lung cancer cell lines.
    Whang YM; Park KH; Jung HY; Jo UH; Kim YH
    Cancer; 2009 Mar; 115(6):1253-66. PubMed ID: 19156899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quinolone analogue inhibits tubulin polymerization and induces apoptosis via Cdk1-involved signaling pathways.
    Chen YC; Lu PH; Pan SL; Teng CM; Kuo SC; Lin TP; Ho YF; Huang YC; Guh JH
    Biochem Pharmacol; 2007 Jun; 74(1):10-9. PubMed ID: 17475221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pseudolaric acid B, a novel microtubule-destabilizing agent that circumvents multidrug resistance phenotype and exhibits antitumor activity in vivo.
    Wong VK; Chiu P; Chung SS; Chow LM; Zhao YZ; Yang BB; Ko BC
    Clin Cancer Res; 2005 Aug; 11(16):6002-11. PubMed ID: 16115945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel oral indoline-sulfonamide agent, N-[1-(4-methoxybenzenesulfonyl)-2,3-dihydro-1H-indol-7-yl]-isonicotinamide (J30), exhibits potent activity against human cancer cells in vitro and in vivo through the disruption of microtubule.
    Liou JP; Hsu KS; Kuo CC; Chang CY; Chang JY
    J Pharmacol Exp Ther; 2007 Oct; 323(1):398-405. PubMed ID: 17660383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of microtubule-interfering halogenated noscapine analogs that perturb mitosis in cancer cells followed by cell death.
    Aneja R; Vangapandu SN; Lopus M; Viswesarappa VG; Dhiman N; Verma A; Chandra R; Panda D; Joshi HC
    Biochem Pharmacol; 2006 Aug; 72(4):415-26. PubMed ID: 16780803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. XN05, a novel synthesized microtubule inhibitor, exhibits potent activity against human carcinoma cells in vitro.
    Wu R; Ding W; Liu T; Zhu H; Hu Y; Yang B; He Q
    Cancer Lett; 2009 Nov; 285(1):13-22. PubMed ID: 19647933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 4'-methoxy-2-styrylchromone a novel microtubule-stabilizing antimitotic agent.
    Marinho J; Pedro M; Pinto DC; Silva AM; Cavaleiro JA; Sunkel CE; Nascimento MS
    Biochem Pharmacol; 2008 Feb; 75(4):826-35. PubMed ID: 18036572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BPR0C261 is a novel orally active antitumor agent with antimitotic and anti-angiogenic activities.
    Hu CB; Chen CP; Yeh TK; Song JS; Chang CY; Chuu JJ; Tung FF; Ho PY; Chen TW; Lin CH; Wang MH; Chang KY; Huang CL; Lin HL; Li WT; Hwang DR; Chern JH; Hwang LL; Chang JY; Chao YS; Chen CT
    Cancer Sci; 2011 Jan; 102(1):182-91. PubMed ID: 21040217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a novel nitro-derivative of noscapine for the potential treatment of drug-resistant ovarian cancer and T-cell lymphoma.
    Aneja R; Vangapandu SN; Lopus M; Chandra R; Panda D; Joshi HC
    Mol Pharmacol; 2006 Jun; 69(6):1801-9. PubMed ID: 16517755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel isocoumarin derivative induces mitotic phase arrest and apoptosis of human multiple myeloma cells.
    Kawano T; Agata N; Kharbanda S; Avigan D; Kufe D
    Cancer Chemother Pharmacol; 2007 Feb; 59(3):329-35. PubMed ID: 16830153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetic stabilization of microtubule dynamics by estramustine is associated with tubulin acetylation, spindle abnormalities, and mitotic arrest.
    Mohan R; Panda D
    Cancer Res; 2008 Aug; 68(15):6181-9. PubMed ID: 18676841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An in vitro investigation of the induction of apoptosis and modulation of cell cycle events in human cancer cells by bisphenanthroline-coumarin-6,7-dioxacetatocopper(II) complex.
    Thati B; Noble A; Creaven BS; Walsh M; Kavanagh K; Egan DA
    Chem Biol Interact; 2007 Jun; 168(2):143-58. PubMed ID: 17512508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytotoxic activity and cytostatic mechanism of novel 2-arylbenzo[b]furans.
    Yang H; Pang JY; Cai YC; Xu ZL; Xian LJ
    J Pharm Pharmacol; 2006 Sep; 58(9):1281-7. PubMed ID: 16945188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of novel 2-N-aryl-substituted benzenesulfonamidoacetamides: orally bioavailable tubulin polymerization inhibitors with marked antitumor activities.
    Liu Z; Zhou Z; Tian W; Fan X; Xue D; Yu L; Yu Q; Long YQ
    ChemMedChem; 2012 Apr; 7(4):680-93. PubMed ID: 22311585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.